Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bozarth

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
Relationship between phosphatidylinositol turnover and Ca++ mobilization induced by alpha-1 adrenoceptor stimulation in the rat aortaA T Chiu, J M Bozarth, P B Timmermans
Cardiovascular Research|September 7, 2000
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levelsS A Mousa, J M Bozarth, M S Forsythe, et al.
British Journal of Pharmacology|May 26, 2001
Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for RoxifibanS A Mousa, J M Bozarth, U P Naik, et al.
Coronary Artery Disease|July 1, 1998
Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosisS A Mousa, J M Bozarth, S Edwards, et al.
Cardiology|January 1, 1993
Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1S A Mousa, M S Forsythe, J M Bozarth, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrateA T Chiu, J M Bozarth, M S Forsythe, et al.
Coronary Artery Disease|November 1, 1994
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728S A Mousa, M S Forsythe, M Diemer, et al.
Thrombosis Research|March 15, 1995
Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptideP W Tsao, J M Bozarth, S A Jackson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dogT M Reilly, S A Mousa, A L Racanelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudinT M Reilly, R M Knabb, S M Hassell, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
Relationship between phosphatidylinositol turnover and Ca++ mobilization induced by alpha-1 adrenoceptor stimulation in the rat aortaA T Chiu, J M Bozarth, P B Timmermans
Cardiovascular Research|September 7, 2000
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levelsS A Mousa, J M Bozarth, M S Forsythe, et al.
British Journal of Pharmacology|May 26, 2001
Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for RoxifibanS A Mousa, J M Bozarth, U P Naik, et al.
Coronary Artery Disease|July 1, 1998
Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosisS A Mousa, J M Bozarth, S Edwards, et al.
Cardiology|January 1, 1993
Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1S A Mousa, M S Forsythe, J M Bozarth, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrateA T Chiu, J M Bozarth, M S Forsythe, et al.
Coronary Artery Disease|November 1, 1994
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728S A Mousa, M S Forsythe, M Diemer, et al.
Thrombosis Research|March 15, 1995
Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptideP W Tsao, J M Bozarth, S A Jackson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dogT M Reilly, S A Mousa, A L Racanelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudinT M Reilly, R M Knabb, S M Hassell, et al.
Pageof 2